维普中文期刊产品整合服务
6篇 您的检索式:作者名="Dietmar Fuchs"
    题名 作者 年代 出处 被引量
1Antioxidants,inflammation and cardiovascular disease显示文摘Multiple factors are involved in the etiology of cardiovascular disease(CVD). Pathological changes occur in a variety of cell types long before symptoms become apparent and diagnosis is made. Dysregulation of physiological functions are associated with the activation of immune cells,leading to local and finally systemic inflammation that is characterized by production of high levels of reactive oxygen species(ROS). Patients suffering from inflammatory diseases often present with diminished levels of antioxidants either due to insufficient dietary intake or,and even more likely,due to increased demand in situations of overwhelming ROS production by activated immune effector cells like macrophages. Antioxidants are suggested to beneficially interfere with diseases-related oxidative stress,however the interplay of endogenous and exogenous antioxidants with the overall redox system is complex. Moreover,molecular mechanisms underlying oxidative stress in CVD are not fully elucidated. Metabolic dybalances are suggested to play a major role in disease onset and progression. Several central signalingpathways involved in the regulation of immunological,metabolic and endothelial function are regulated in a redox-sensitive manner. During cellular immune response,interferon γ-dependent pathways are activated such as tryptophan breakdown by the enzyme indoleamine 2,3-dioxygenase(IDO) in monocyte-derived macrophages,fibroblasts,endothelial and epithelial cells. Neopterin,a marker of oxidative stress and immune activation is produced by GTP-cyclohydrolase Ⅰ in macrophages and dendritic cells. Nitric oxide synthase(NOS) is induced in several cell types to generate nitric oxide(NO). NO,despite its low reactivity,is a potent antioxidant involved in the regulation of the vasomotor tone and of immunomodulatory signaling pathways. NO inhibits the expression and function of IDO. Function of NOS requires the cofactor tetrahydrobiopterin(BH4),which is produced in humans primarily by fibroblasts and endothelial cells. Highly toxic peroxynitrite(ONOO-) is formed solely in the presence of superoxide anion(O2-). Neopterin and kynurenine to tryptophan ratio(Kyn/Trp),as an estimate of IDO enzyme activity,are robust markers of immune activation in vitro and in vivo. Both these diagnostic parameters are able to predict cardiovascular and overall mortality in patients at risk. Likewise,a significant association exists between increase of neopterin concentrations and Kyn/Trp ratio values and the lowering of plasma levels of vitamin-C,-E and-B. Vitamin-B deficiency is usually accompanied by increased plasma homoycsteine. Additional determination of NO metabolites,BH4 and plasma antioxidants in patients with CVD and related clinical settings can be helpful to improve the understanding of redox-regulation in health and disease and might provide a rationale for potential antioxidant therapies in CVD.Harald Mangge Kathrin Becker Dietmar Fuchs Johanna M Gostner 2014World Journal of Cardiology2014,6,6:25
2Neopterin, a prognostic marker in human malignancies显示文摘Robert Sucher Katharina Schroecksnadel Guenter Weiss Raimund Margreiter Dietmar Fuchs Gerald Brandacher 2009Cancer Letters2009,,1:2
3Tryptophan degradation to control T-cell responsiveness显示文摘Bernhard Widner Günter Weiss Dietmar Fuchs 2000Immunology Today2000,,5:1
4Association between Increased Serum Cholesterol and Signs of Depressive Mood显示文摘Maximilian Ledochowski Christian Murr Barbara Sperner-Unterweger Gabriele Neurauter Dietmar Fuchs 2003Clinical Chemistry and Laboratory Medicine2003,,6:1
5On the Role of Intestinal Microbiota in Patients with Cognitive Decline显示文摘Friedrich Leblhuber Barbara Strassert Kostja Steiner Johanna Gostner Burkhard Schuetz Dietmar Fuchs 2017Journal of Pharmacy and Pharmacology2017,5,9:0
6炎症试验显示文摘草药被用于治疗已经有很多个年代。当开始使用现代化学疗法时,草药疗法就不常用了,但近年来这种疗法又开始盛行。他们用于保养和小病小恙的治疗和预防,像普通的感冒或心烦气躁,但有时也用于治疗比较严重的疾病,特别是像类风湿性关节炎、慢性神经紊乱或抑郁症等慢性疾病。有迹象表明:草药的部分功能与能够改善或使免疫细胞功能正常化活动有关。Dietmar Fuchs 2006经济导报(医药技术)2006,,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费